BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 27, 2013
View Archived Issues
Phase I data presented for RPC-1063 in IBD patients
Read More
Complementary biomarker for the diagnosis of gastrointestinal carcinoma described
Read More
Partnership to advance fusion protein for NHL
Read More
Results presented for Pulmagen's lead oral DP2 receptor antagonist ADC-3680
Read More
Blood thiamine metabolism as a non-invasive biomarker for AD diagnosis
Read More
HGT-1410 demonstrates rapid systemic distribution in vivo
Read More
New inhibitors of phosphate transport synthesized by Astellas
Read More
Merck & Co. patents novel GPR119 receptor agonists
Read More
Canadian group discloses new CBX2 modulators for cancer
Read More
Novel FABP inhibitors divulged by Roche
Read More
Merck & Co. presents novel bacterial vaccines
Read More
Companies announce termination of QVAR comarketing agreement
Read More
Rigel Pharmaceuticals set to advance to phase II trial for dry eye disease therapeutic
Read More
Scientists at Merck & Co. synthesize novel gamma-secretase modulators
Read More
HbA1c test receives marketing approval in U.S. for diabetes diagnosis
Read More
TauRx Therapeutics opens U.K. sites in phase III trials of LMTX
Read More
Bayer Yakuhin launches Stivarga tablets in Japan
Read More
Merck & Co. discontinues development of preladenant for Parkinson's disease
Read More
PharmaMar studies PM-01183 in combination with capecitabine
Read More
Nippon Shinyaku launches Regtect in Japan
Read More
Mitsubishi Tanabe Pharma seeks Japanese approval of canagliflozin
Read More
OncoTherapy Science obtains rights to results of collaborative research with Kumamoto University
Read More
Data show GCS-100 may improve renal function
Read More
Astellas submits marketing application in Japan for enzalutamide
Read More
Dosing begins in phase I trial of SB-9200 in HCV infection
Read More
Headline results reported from phase IIIa trial of liraglutide for obesity
Read More